4 States Tell FDA That REMS Restrictions Are Unneeded For Mifepristone

( June 6, 2025, 11:15 AM EDT) -- The attorneys general of California, Massachusetts, New Jersey and New York on June 5 submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to remove the Risk Evaluation and Mitigation Strategy (REMS) restrictions on mifepristone, one of the two drugs prescribed for medication abortions....

Attached Documents

Related Sections